Skip to main content

Animations

MJFF Publications

7731 - 7740 of 8785 Results
Title
Year
  • Year
  • 2014
  • 2021
  • 2023
  • 2017
  • 2018
  • 2018
  • 2018
  • 2016
  • 2025
  • 2020
  • Summary Details
    OPEN
    Title: Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2013.12.011
    Citation Count: 81
  • Summary Details
    OPEN
    Title: Assessment of ANG variants in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.03.006
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Regulatory imbalance between LRRK2 kinase, PPM1H phosphatase, and ARF6 GTPase disrupts the axonal transport of autophagosomes
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2023.112448
    Citation Count: 28
  • Summary Details
    OPEN
    Title: The LRR-Roc-COR module of theChlorobium tepidumRoco protein: crystallization and X-ray crystallographic analysis
    Journal Name: Acta Crystallographica Section F Structural Biology Communications
    Publisher: International Union of Crystallography (IUCr)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1107/s2053230x17011955
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery
    Journal Name: Journal of Controlled Release
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jconrel.2018.08.006
    Citation Count: 87
  • Summary Details
    OPEN
    Title: A pathway for Parkinson’s Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.40202
    Citation Count: 238
  • Summary Details
    OPEN
    Title: Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease
    Journal Name: Journal of Tissue Engineering and Regenerative Medicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/term.2698
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.17111
    Citation Count: 55
  • Summary Details
    RESTRICTED
    Title: Reply to: “Early Indian Age at Onset of Parkinson's: A Case for a Gene‐Environment Lens”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70053
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.